Clinical trial NCT05127707: Strategies to Reduce Addiction Stigma Among Health Professionals
Official title: Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Professionals: A Randomized Experiment
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Opioid Use Disorder
Substance Use Disorders
Stigma, Social
Lead sponsor: Johns Hopkins Bloomberg School of Public Health
Sponsor class: OTHER
First posted: 2021-11-19
Enrollment: 1842
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.

Detailed description: This randomized experiment evaluated the impact of exposure to message frames communicating the importance of non-stigmatizing language regarding addiction and the effectiveness of medication treatment for opioid use disorder delivered through a visual campaign alone or through a visual campaign in addition to a narrative vignette from the perspective of one of three messengers (a person with opioid use disorder, a clinician, or a health system leader) on attitudes toward people with opioid use disorder and medications for treating opioid use disorder among a national sample of health professionals.

Eligibility criteria: Inclusion Criteria:

* employed as health professional in the United States, including clinicians (e.g., physicians, nurses, physician assistants, pharmacists, and optometrists), technicians and technologists (e.g., laboratory technologist or technician, emergency medical technician, paramedic, licensed practical or licensed vocational nurse, medical records or health information technician, etc.), health aids and assistants (e.g., nursing aide, home health aide, medical assistant, pharmacy aide, phlebotomist, etc.)
* participant in existing web-based survey panel (IPSOS's KnowledgeNetworks panel and partner opt-in panel)

Exclusion Criteria:

* not employed in health profession
* not able to complete experiment and survey in English

Primary outcomes:
measure: Rating of willingness to have person with opioid use disorder marry into their family
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of willingness to have person with opioid use disorder as a neighbor
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of agreement that opioid use disorder is a medical condition
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of agreement that individuals with opioid use disorder are to blame
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of support for increasing government spending on opioid use disorder treatment
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Feeling thermometer measure of warmth toward people with opioid use disorder
timeFrame: Measured immediately post-exposure to message frame intervention
Secondary outcomes:
measure: Stigmatizing Language - Addict
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - Substance abuse
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - dirty
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - clean
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - addicted baby
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - person with substance use disorder
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - substance use
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - negative test result
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - positive test result
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Stigmatizing Language - baby born with neonatal opioid withdrawal syndrome
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Willingness to sign pledge committing to using non-stigmatizing language
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Perception of opioid use disorder treatment effectiveness
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of willingness to have person taking medication marry into their family
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of willingness to have person taking medication marry as a neighbor
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of strength/weakness of person taking medication
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Rating of agreement that recovery is possible
timeFrame: Measured immediately post-exposure to message frame intervention
measure: Feeling thermometer measure of warmth toward people taking medication
timeFrame: Measured immediately post-exposure to message frame intervention
Other outcomes:
Locations:
city: Baltimore
country: United States
facility: Johns Hopkins Bloomberg School of Public Health
state: Maryland
Study officials:
affiliation: Johns Hopkins Bloomberg School of Public Health
name: Alene Kennedy-Hendricks, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kennedy-Hendricks A, McGinty EE, Summers A, Krenn S, Fingerhood MI, Barry CL. Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Care Professionals: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e2146971. doi: 10.1001/jamanetworkopen.2021.46971.